Exforge HCT 10-160-12.5 MG tab 30S
Ended Awarded
- Contract number
- SPE2DB25FVKW8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,171
Award facts
- Contract value 100% obligated
- $1,171.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,171.24 to AmerisourceBergen Drug Corp for Exforge HCT 10-160-12.5 mg tablets (30-count supply) on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized healthcare commodities. The company's contract awards with DLA demonstrate its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, from specialty medications to routine supplies. This particular delivery order for the antihypertensive medication Exforge HCT exemplifies the routine pharmaceutical procurement conducted under the larger DLA global pharmaceutical support framework, which enables flexible supply chain management for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FVKW8?
SPE2DB25FVKW8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FVKW8 worth?
The government has obligated $1,171 on SPE2DB25FVKW8.
Is contract SPE2DB25FVKW8 an order under another contract?
Yes. SPE2DB25FVKW8 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVKW8 competed?
The extent of competition for SPE2DB25FVKW8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award